Bicara Therapeutics Inc. (BCAX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BCAX currently has 60.7M outstanding shares. with moderate dilution risk from 16.9M authorized shares representing 27.9% potential dilution. The company has significantly diluted shareholders by 37.89% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 11, 2026 |
10-Q filing | 60.7M shares outstanding |
61M | 17M |
| Mar 30, 2026 |
10-K filing | 65.5M shares outstanding |
65M | 17M |
| Nov 10, 2025 |
10-Q filing | 54.6M shares outstanding |
55M | 17M |
| Oct 03, 2025 |
S-3 filing: The company is filing an S-3 to register the offering of up to $400,000,000 in aggregate principal amount of our common stock, preferred stock, debt securities, warrants and/or units, in any combination, and also registering an offering of up to $150,000,000 shares of common stock through a sales agent. |
55M | 17M |
| Aug 12, 2025 |
10-Q filing | 54.5M shares outstanding |
55M | 17M |
| May 13, 2025 |
10-Q filing | 54.5M shares outstanding |
54M | 17M |
| Mar 27, 2025 |
10-K filing | 54.5M shares outstanding |
55M | 17M |
| Nov 12, 2024 |
10-Q filing | 54.4M shares outstanding |
54M | 17M |
| Sep 11, 2024 |
S-1/A filing: The company is offering 14,705,882 shares of common stock in an initial public offering, with an expected price between $16.00 and $18.00 per share, and has granted the underwriters an option to purchase an additional 2,205,882 shares. |
49M | 17M |
| Sep 06, 2024 |
S-1/A filing: The company is offering 11,765,000 shares of common stock in an initial public offering with an expected price range of $16.00 to $18.00 per share and has granted the underwriters an option to purchase an additional 1,764,750 shares. |
46M | 14M |
| Sep 03, 2024 |
S-1/A filing: The company is offering shares of its common stock in an initial public offering and has applied to list its common stock on The Nasdaq Global Market under the symbol BCAX. |
320M | 0 |
| Aug 22, 2024 |
S-1 filing: The company is offering shares of its common stock in an initial public offering and has applied to list its common stock on The Nasdaq Global Market under the symbol BCAX. |
320M | 0 |